This study enrolls adults with schizophrenia who are currently in a treatment program for schizophrenia and your clinician is prescribing a Long Read More

Adults ages 18+.
Diagnosis of schizophrenia.
Have just started treatment with one of four atypical Long Acting Injectable (LAI) medications (ABILIFY MAINTENA, ARISTADA, INVEGA SUSTENNA or RISPERDAL CONSTA)

This study enrolls adults with a blockage in an artery in their heart that needs to be tested to determine if it should be treated. The purpose of this study is to collect data and measurements to find out if you need you need an interventional procedure to open your blood vessel or artery. Read More

Adults ages 18+.
Have at least 1 non-stented lesion in 1 or more major epicardial vessels of 40-90% angiographic stenosis.

This study enrolls adults with Congenital Adrenal Hyperplasia. The purpose of this study is to see if an investigational drug called tildacerfont is safe and effective in reducing the level of certain hormones in your body. Read More

Adults ages 18-55.
Has a documented historical diagnosis of classic Congenital Adrenal Hyperplasia (CAH)

This study enrolls people who have been diagnosed with a blood clot blocking an artery in their brain (stroke). The blocked artery is opened by removing the blood clot using a small catheter (thin tube) device that is inserted into an artery through your arm or leg that leads to your brain. The purpose of this study is to find out if this specific new investigational catheter (ZOOM) leads to improved outcomes at 90 days. Read More

Adults ages 18+
Diagnosed with a stroke
Nonpregnant females

This study enrolls adults with nonalcoholic steatohepatitis (NASH). The purpose of this study is to learn about how much a medication called tirzepatide can help people with this condition. Read More

Adults ages 18-80.
Overweight or obese.
Diagnosis of NASH by liver biopsy in the past 6 months.
Have fibrosis stage 2 or 3.

This study enrolls people who have been diagnosed with Tricuspid Regurgitation (TR). The purpose of this study is to look at the safety and effectiveness of this new investigational device compared to the standard medical treatment. Read More

Adults ages 18+
Diagnosed with Tricuspid Regurgitation/Insufficiency

This is a 26-week open-label study to evaluate the safety and effectiveness of the study drug in the treatment of pediatric participants with schizophrenia or bipolar I disorder. Read More

Males and females ages 13 to 18 with schizophrenia or 10 to 18 years of age with bipolar I disorder may be eligible for the study.

This study enrolls women who will be having a hysterectomy. Our goal is to create a non-opioid pain medication plan that will make opioid pain medications less needed after surgery. Read More

Adults ages 18+.
Women undergoing a robotic hysterectomy who do not have current opioid prescription or current opioid addiction.

This study enrolls children and young adults with congenital anomalies of the kidney and urinary tract (CAKUT). The purpose of the study is to learn which gene mutation(s) may be responsible for this condition and to eventually find a gene therapy to treat this condition. Read More

Children and young adults ages 0-21 years old with CAKUT (congenital anomalies of the kidney and urinary tract) seen at Oshei Children's Hospital
Patient's family member without CAKUT.

The purpose of this study is to develop a device to help people after they have had a stroke. This study looks at how the wrist moves when a person does everyday activities. Read More

-Adults ages 18-65.
-Healthy and fit to perform active daily living tasks.